Notice for macitentan (Janssen-Cilag Pty Ltd)
Active ingredients
macitentan
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
dispersible tablet
Indication
Treatment of pulmonary arterial hypertension in paediatric patients
Therapeutic area
Cardiovascular